|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
|1 - 9999|
Drugs: Recently, the FDA’s Office of International Programs (OIP) said it is exploring a single, global drug recall system that would encompass all domestic and international drug recalls.
Devices: Both CDRH and Health Canada plan to issue guidance soon on what evidence acceptably shows that a company’s recalls has been effective. These recall strategies are expected to document supply chain communications down to the patient.
No one can argue that it seems the FDA appears to be taking a tough stance on recall strategy. Are you ready?
Now, more than ever, you need a proactive recall strategy, one that includes the United States and every other country in which your products are sold.
Like it or not — despite the complicated process you have to go through to receive regulatory approval — product recalls are a reality, in the U.S. and in every other country where your product is sold.
Those unprepared will see millions siphoned from their bottom lines — spent on everything from damage control advertisements to public relations experts — with countless man-hours wasted on spin control instead of new product development.
Attend and you’ll get a complete, electronic playbook containing a specific,
comprehensive and actionable strategy for global recall planning.
It’s yours FREE with your paid registration!
With the encore presentation, you can gain piece of mind that you are ready if a recall occurs.
International Drug and Device Recalls: the 90-minute FDAnews webinar that shows you how to craft a master global recall strategy to protect your product from the toughest regulatory storms, at home and abroad — solidly based on the regulations of the FDA, World Health Organization, European Medicines Agency and the Health Protection Branch of Health Canada.
Noted attorney James M. Wood of Reed Smith returns to share with you his proactive, proven international plan for recalls — each step carefully developed from lessons learned in three decades representing manufacturers of prescription medicines and medical devices. You will complete this encore presentation with all you need to successfully:
There’s more. From the comfort of your own office, International Drug and Device Recalls even gives you situation-specific advice on the “gray areas” of global recalls:
Mr. Wood has received rave reviews from prior FDAnews presentations, including:
"It was well organized. The presenter was prepared and gave good verbal example and gave me ideas on how to improve our recall process."
"Strong internal recalls presentation and good fielding of questions."
And like every FDAnews encore presentation, International Drug and Device Recalls is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether you’re at the office or telecommuting from your office-in-home.
No company ever wants to face a recall. But recalls will happen — and an FDA “seal of approval” is no guarantee you’ll escape it.
Get your proactive international recall plan in place before it’s too late: attend James M. Wood’s repeat performance of International Drug and Device Recalls — and claim your FREE BONUS: the complete, electronic playbook of specific, actionable strategies for global recall planning. Brought to you by FDAnews.
James M. Wood is a noted attorney with Reed Smith. His practice for 32 years has focused on the representation of manufacturers of prescription medicines and medical devices. He has represented and counseled manufacturers of prescription products involving a variety of issues. These have included recalls of prescription products, marketing and promotion of these products, First Amendment issues in marketing these products, off-label issues, preemption, product liability issues and the reuse of single-use medical devices.
Based on this experience, he has recently co-authored a book that details planning for and implementing the recall process for all regulated products, Prescription Product Recalls — A Proactive Primer. He has also served as regional counsel for an international medical device company in a product liability action and was the multi-district litigation liaison counsel in the Gammagard® MDL litigation.
|Date:||Dec. 10–28, 2012|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
Significant tuition discounts are available for three or more sites from
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing